SCHEMBL24477307

SCHEMBL24477307

Cc1cc(C#N)n2ncc(C(=O)NCc3ccc(-c4cnco4)cc3C)c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.44
HPGD P15428 9/20 0.44
KDM4E B2RXH2 9/20 0.44
HSD17B10 Q99714 3/20 0.43
CYP1A1 P04798 1/20 0.42
TSHR P16473 3/20 0.42
USP2 O75604 1/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
RECQL P46063 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPK10 P53779 1/20 0.42
POLB P06746 3/20 0.39
MAPT P10636 4/20 0.39
NPSR1 Q6W5P4 4/20 0.39
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MAPK1 P28482 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24477303 0.89 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EHSD17B10CYP1A1
SCHEMBL24477291 0.82 TYK2 (0.42) ALDH1A1HPGDKDM4EHSD17B10CYP1A1
SCHEMBL24477304 0.81 ALDH1A1 (0.59) ALDH1A1HPGDKDM4EHSD17B10CYP1A1
SCHEMBL24477486 0.80 GSK3A (0.48) ALDH1A1HPGDKDM4EHSD17B10CYP1A1
SCHEMBL24477294 0.76 APOBEC3A (0.39) ALDH1A1HPGDKDM4EHSD17B10CYP1A1
SCHEMBL24477481 0.74 TYK2 (0.42) ALDH1A1HPGDKDM4EHSD17B10POLB
SCHEMBL24477483 0.72 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EHSD17B10CYP1A1
SCHEMBL24477292 0.72 MAPT (0.36) ALDH1A1HPGDKDM4EHSD17B10CYP1A1
SCHEMBL24477309 0.69 POLB (0.43) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL22767222 0.67 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EHSD17B10CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220169652-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS INC. 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220169652-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS PARK7, PNP, GAA ALDH1A1 1213/4885HPGD 1396/4885KDM4E 899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.